![Sio Gene Therapies Inc. logo](/logos/SIOX.webp)
Sio Gene Therapies Inc.
NASDAQ:SIOX
Overview | Financials
Company Name | Sio Gene Therapies Inc. |
Symbol | SIOX |
Currency | USD |
Price | 0.415 |
Market Cap | 30,699,708 |
Dividend Yield | 91% |
52-week-range | 0.415 - 0.415 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. David W. Nassif J.D. |
Website | https://www.siogtx.com |
An error occurred while fetching data.
About Sio Gene Therapies Inc.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD